文献速递外周血管腹部MRPET

革新腹主动脉瘤诊断:分子影像的前景

Revolutionizing Abdominal Aortic Aneurysm Diagnosis: The Promise of Molecular Imaging.
PubMed 文献 · Acad Radiol · 2025-04-05

本文综述腹主动脉瘤的病理生理演变、对比剂与分子探针原理,以及临床前模型中血管壁分子影像的最新进展,指出分子影像可在分子水平高空间分辨率显示病理过程,有望超越解剖尺寸表征腹主动脉瘤,弥补早期诊断与靶向治疗的不足。

要点

  • 腹主动脉瘤早期常无症状,现有风险评估主要依赖瘤体大小和生长速率,不足以识别高危个体。
  • 分子影像可在分子水平高空间分辨率显示血管壁病理过程,有望超越解剖尺寸表征腹主动脉瘤。
  • 综述聚焦临床前模型中血管壁分子影像的原理与最新进展。

核心结论

  • 分子影像技术可在分子水平高空间分辨率显示病理过程,为超越解剖尺寸表征腹主动脉瘤、弥补早期诊断与靶向治疗不足提供了有前景的机会。

研究设计与样本

  • 综述,聚焦腹主动脉瘤的临床前模型及分子影像技术的发展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Abdominal aortic aneurysm (AAA) is a potentially fatal condition that is often asymptomatic in its early stages, with treatment strategies that remain controversial due to limited predictive accuracy for rupture risk. Current clinical approaches primarily rely on aneurysm size and growth rates for risk assessment, which are insufficient for identifying high-risk individuals. This review focuses on preclinical models and the development of molecular imaging technologies, which offer high-spatial-resolution visualization of pathological processes at the molecular level. These advancements provide a promising opportunity to characterize AAA beyond anatomical dimensions and address existing gaps in early diagnosis and targeted therapy. We will discuss the progression of pathophysiological alterations in AAA, the principles underlying contrast agents and molecular probes, and recent advancements in vascular wall molecular imaging within preclinical models.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Zhang P. Revolutionizing Abdominal Aortic Aneurysm Diagnosis: The Promise of Molecular Imaging. Acad Radiol. 2025. PMID: 40189466. doi:10.1016/j.acra.2025.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。